Health
First human trial of Oxford COVID-19 vaccine shows promise – Reuters
An experimental vaccine being developed by AstraZeneca and Oxford University against the new coronavirus produced an immune response in early-stage clinical trials, data showed on Monday, preserving hopes it could be in use by the end of the year.
LONDON (Reuters) – An experimental vaccine being developed by AstraZeneca and Oxford University against the new coronavirus produced an immune response in early-stage clinical trials, data showed on Monday, preserving hopes it could be in use by the end of the year.
The vaccine, called AZD1222, has been described by the World Health Organization’s chief scientist as the leading candidate in a global race to halt a pandemic that has killed more than 600,000 people.
More than 150 possible vacc…
-
General20 hours agoThree NT residents charged with fraud over alleged $71 million Defence contract scheme
-
General18 hours agoVote counting begins for Townsville mayoral by-election
-
Noosa News24 hours agoThe ‘gun’ shearer still setting a cracking pace at 85
-
Noosa News23 hours agoQueensland GPs to be able to diagnose adults with attention deficit hyperactivity disorder from December 1